Skip to content
Trial Eligibility
Menu

Localized Injection of Lidocaine Via the Middle Meningeal Artery for Headache Treatment

NCT07361549

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

The goal of this clinical trial is to test whether injecting lidocaine into two blood vessels of the brain can help treat chronic headaches (migraines)

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Refractory Migraine
  • Headache

Eligibility basics and study details

Study type
Interventional
Phase
Phase 2
Ages
18 years and older
Sex
All
Healthy volunteers
Not accepted
Sponsor
Daniel A Tonetti, MD
Last updated on ClinicalTrials.gov
October 1, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

New Jersey · 1

  • Cooper University Health Care · Camden, NJ

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.